The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo. - Wikidata - awgldk - TriplyDB

The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo.

The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo.

http://www.wikidata.org/entity/Q34614251

about

Celiac disease: prevalence, diagnosis, pathogenesis and treatment In vivo fluorescence imaging of exogenous enzyme activity in the gastrointestinal tract Gliadin-Specific T-Cells Mobilized in the Peripheral Blood of Coeliac Patients by Short Oral Gluten Challenge: Clinical Applications Therapeutic approaches for celiac disease The clinical response to gluten challenge: a review of the literature Current and emerging therapy for celiac disease Properties of Gluten Intolerance: Gluten Structure, Evolution, Pathogenicity and Detoxification Capabilities Celiac disease: From pathophysiology to treatment.Identification of gliadin-binding peptides by phage display.Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells.Novel therapies for coeliac disease BL-7010 demonstrates specific binding to gliadin and reduces gluten-associated pathology in a chronic mouse model of gliadin sensitivity.The present and the future in the diagnosis and management of celiac disease.Prevention measures and exploratory pharmacological treatments of celiac disease.Measuring hordein (gluten) in beer--a comparison of ELISA and mass spectrometry.Update on celiac disease - etiology, differential diagnosis, drug targets, and management advances.Celiac disease: a disorder emerging from antiquity, its evolving classification and risk, and potential new treatment paradigms.Sourdough fermentation of wheat flour does not prevent the interaction of transglutaminase 2 with α2-gliadin or gluten Ineffective degradation of immunogenic gluten epitopes by currently available digestive enzyme supplements Effect of anti-gliadin IgY antibody on epithelial intestinal integrity and inflammatory response induced by gliadin.Analysis of Body Composition and Food Habits of Spanish Celiac Women.Interest in medical therapy for celiac disease.Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease Celiac disease: advances in treatment via gluten modification Pharmacotherapy and management strategies for coeliac disease.Future treatment strategies for celiac disease.The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet.Evolving molecular targets in the treatment of nonmalignant gastrointestinal diseases.Latest in vitro and in vivo models of celiac disease.Advances in the treatment of coeliac disease: an immunopathogenic perspective.Improving the stability and activity of oral therapeutic enzymes-recent advances and perspectives.Celiac disease: the search for adjunctive or alternative therapies.Current status of drugs in development for celiac disease.Emerging drugs for coeliac disease.Emerging drugs for celiac disease.Immunochemical Detection Methods for Gluten in Food Products: Where Do We Go from Here?Personalizing protein nourishment Molecular characterization of gluten hydrolysing Bacillus sp. and their efficacy and biotherapeutic potential as probiotics using Caco-2 cell line.Lack of immunogenicity of hydrolysed wheat flour in patients with coeliac disease after a short-term oral challenge.Commercially available glutenases: a potential hazard in coeliac disease.

P2860

Q22305490-B58C273A-F5F4-4387-A309-689409A76C5F Q24627253-44639115-0519-45CC-9C84-66BD8203AD72 Q26775020-C6000536-CA38-4488-962F-DE10234DD044 Q26825413-068442F5-CE38-463C-BC0A-A7CA7FAB1A72 Q26830641-9F2761E9-0B23-4C7A-937B-940B1DBD5C2A Q27014843-C2A5EDD4-5FBB-4C34-9B72-7A906F1CE37E Q28072666-0CB07B82-31C7-4964-8BB6-A2E659FB6A17 Q30234291-07B8D358-09A7-4726-A29B-D63C65168887 Q33823074-18D6DE41-9BFF-4528-A736-9C004D8B45E9 Q34022801-A4FC8526-3290-43A6-BC4F-0F09BAF7B515 Q34170574-D442A442-DADE-4878-933A-E384941EB159 Q34443779-3F6D0325-2DAD-451C-BB9D-EB5480730116 Q34444067-966ADBD7-8F11-4844-B578-75CC7BFF9F2C Q34623902-0F136883-C255-4279-8743-2599AB920CF9 Q34627268-20F9520F-5C5C-4077-82DB-DA7D2751E669 Q34635029-303C2C93-3679-4945-9D92-7884B870C6AE Q34809320-95A73C89-C158-4157-BCA1-873A3B314B77 Q35585826-2E036F10-EA81-458E-AA80-7F5D4B16558F Q35647827-FAA4DBB6-5852-4A58-9104-6368646BFAC7 Q35686518-6FE67602-F13A-4F3B-9D9F-2583C6B9AF46 Q35895022-E9978390-4440-451C-87C8-9A17411E2942 Q37130612-1C140C1A-5B8A-47F2-9B62-FDE2779720FC Q37144602-5D6499D2-6B7D-49C0-9CF7-934013E2D486 Q37210843-F9D374D4-3444-45E5-A485-45B43749A6CE Q37896092-8AB49F32-596E-41F4-9623-15A4ACB87B7C Q38012460-AAB3D219-FA64-4612-91FD-B8D0F15827E1 Q38016781-A16279EC-6988-4AE0-80BA-37A7D1CC00A3 Q38029235-B9D2046E-25E3-4704-B258-1C55D70F352B Q38072065-ACB9B242-0A58-43C8-BFE5-2CB302764A39 Q38126789-E754BD93-27A5-4E01-8890-D4F84679FFA0 Q38159436-0D90B95F-43E8-43CF-AF68-2B3275F1262D Q38184586-521CF042-2862-490F-91FD-AE5D07EB02B4 Q38210088-34BFE79F-B44D-44DF-A033-328CB72FB899 Q38248960-9D644A67-A9CD-4244-8307-C2F2491A35E4 Q38286185-839BE798-54C9-40C6-8244-5B7A3A342B4E Q38380946-0468B2A9-65EA-4CF2-9528-0FC8BA83CD21 Q38682079-C63C7B89-F71A-4484-8035-E75138B66A23 Q38699504-5995AC97-30B3-46C1-BBFE-81F6246CC6C1 Q38719873-3F47C4F2-61DF-43BB-8777-FE7F990068E1 Q38752372-FCA99732-442F-4D28-BAF1-724F73A8E4A3

P2860

The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo.

http://www.wikidata.org/entity/Q34614251

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The effects of ALV003 pre-dige ...... oms in celiac disease in vivo.

@ast

The effects of ALV003 pre-dige ...... oms in celiac disease in vivo.

@en

The effects of ALV003 pre-dige ...... oms in celiac disease in vivo.

@nl

type

label

The effects of ALV003 pre-dige ...... oms in celiac disease in vivo.

@ast

The effects of ALV003 pre-dige ...... oms in celiac disease in vivo.

@en

The effects of ALV003 pre-dige ...... oms in celiac disease in vivo.

@nl

prefLabel

The effects of ALV003 pre-dige ...... oms in celiac disease in vivo.

@ast

The effects of ALV003 pre-dige ...... oms in celiac disease in vivo.

@en

The effects of ALV003 pre-dige ...... oms in celiac disease in vivo.

@nl

P1433

Q34614251-86915B78-DC68-4DF0-BEB0-F44F18782C90

P1476

Q34614251-BB226E85-55F6-422C-ABA0-B3973183E8CA

P2093

Q34614251-05BDF1CA-A2EF-447A-8048-C7805B9AB3E1

Q34614251-080E42C8-3082-42F0-B3B6-A54B08DE6383

Q34614251-1BD5E99C-A5BD-45B8-B30E-1AC8AC6C3EE3

Q34614251-390EE806-133F-4647-B6DA-B45CBB8FDD41

Q34614251-3FD86F35-6C93-4F7A-9198-8F80D91E1FAC

Q34614251-68D653F0-E9E4-41D4-A222-D1BBE4222309

Q34614251-C21D896B-0633-48AD-A033-435722ED75D2

Q34614251-DFB39F05-EEF1-498D-9B7E-EBF4C9644EAC

P304

Q34614251-196A2A9A-16F7-4DB9-9A49-7EF5F20918D2

P31

Q34614251-6818188F-A429-403C-B5F1-2348A29B3F6A

P356

Q34614251-796DB0F0-A6F8-4A8C-B34F-B80F6D64DCFD

P433

Q34614251-372A5053-2B48-40BA-B525-1C9599EDD762

P478

Q34614251-6BCF57F2-A0A9-45A9-A293-BECCA461C88C

P577

Q34614251-6FBD38AA-0CE0-4990-AF0A-ED2E694A108B

P698

Q34614251-A3BB9727-47C6-4DB0-BBAD-CF66CE7268CF

P356

J.CLIM.2009.11.001

P1433

Clinical Immunology

P1476

The effects of ALV003 pre-dige ...... oms in celiac disease in vivo.

@en

P2093

Gregor J Brown

http://www.w3.org/2001/XMLSchema#string

Jason A Tye-Din

http://www.w3.org/2001/XMLSchema#string

Matthew Siegel

http://www.w3.org/2001/XMLSchema#string

Peter Hodsman

http://www.w3.org/2001/XMLSchema#string

Revati Shreeniwas

http://www.w3.org/2001/XMLSchema#string

Robert P Anderson

http://www.w3.org/2001/XMLSchema#string

Rosemary A Ffrench

http://www.w3.org/2001/XMLSchema#string

Wendy Botwick

http://www.w3.org/2001/XMLSchema#string

P304

289-295

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLIM.2009.11.001

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19942485

http://www.w3.org/2001/XMLSchema#string